$1.35
0.032.27%
Last update: Nov 4, 9:19 AM
NervGen Pharma Corp
NGENNASDAQ
The average analyst price target for NervGen Pharma is $12.50, 793.8% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $10 to $15. The latest change came on Jul 14, 2026, when HC Wainwright & Co. lowered its price target on NervGen Pharma from $18 to $15 and kept a Buy rating.
Price Target Range — 2 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
